On July 30, 2016, the final participant completed their 12-month follow-up interview in our largest Phase 2 study of MDMA-assisted psychotherapy for 24 U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. All treatment sessions and long-term follow-up interviews for this study have now been completed. Led by Principal Investigator Michael Mithoefer, M.D., and Co-Therapist Annie Mithoefer, B.S.N., in Charleston, South Carolina, the data from this study are now being prepared for analysis and publication in a peer-reviewed scientific journal.
“In the past couple of months we have seen our last two study participants for their one year follow-ups,” explains Annie Mithoefer, B.S.N. “It is really gratifying to see their lives changed for the better and that they are not being run by their PTSD. Over the course of this study we have met some really wonderful people who have been willing to be a part of this rigorous research. Thank you MAPS staff and all the people who have donated money and time to make this healing possible.”
“For us, the end of each of our MDMA/PTSD studies has been a bitter-sweet moment,” states Michael Mithoefer, M.D. “It’s sad saying goodbye to research participants after the privilege of getting to know them and supporting them in their deep healing journeys. It’s a time for celebrating the remarkable results of these journeys, that in so many cases have relieved painful, debilitating symptoms and brought deep healing and fulfilling reengagement in their lives without the daily burden of PTSD.” Learn more…
